BERKSHIRE HEALTH SYSTEMS

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website: https://www.berkshirehealthsystems.org/

Clinical Trials

Levetiracetam in the Treatment of Patients With Premenstrual Dysphoric Disorder (PMDD)

Not Applicable

Completed

Conditions: Premenstrual Dysphoric Disorder

Interventions: Drug: Levetiracetam

First Posted Date: 2007-08-20

Last Posted Date: 2007-08-20

Lead Sponsor: Berkshire Health Systems

Target Recruit Count: 7

Registration Number: NCT00518570

Locations: 🇺🇸
Berkshire Medical Center, Clinical Trials Program, Department of Psychiatry, Pittsfield, Massachusetts, United States

Prev
1
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy